10-QPeriod: Q3 FY2007

COLGATE PALMOLIVE CO Quarterly Report for Q3 Ended Sep 30, 2007

Filed October 30, 2007For Securities:CL

Summary

Colgate-Palmolive Company (CL) reported strong financial performance for the nine months ended September 30, 2007, with net sales increasing by 12.5% to $10.15 billion and net income growing significantly to $1.32 billion. This growth was driven by a combination of volume increases, strategic pricing, positive foreign exchange impacts, and the successful integration of acquisitions, notably Tom's of Maine. The company's core Oral, Personal, and Home Care segment, along with Pet Nutrition, demonstrated robust growth across various geographic regions, underscoring the strength of its global brands and market leadership. Management highlighted operational efficiencies and cost-saving initiatives, including the ongoing 2004 Restructuring Program, which is progressing as planned and expected to yield substantial savings. Despite some ongoing legal and tax matters, particularly in Mexico and Brazil, management expressed confidence in the company's ability to prevail and noted that these are not expected to have a material impact on the financial position or ongoing results. The company's focus on higher-margin businesses and strategic market expansion positions it well for continued growth and shareholder value creation.

Key Highlights

  • 1Net sales for the nine months ended September 30, 2007, increased by 12.5% to $10.15 billion, driven by 7.0% volume growth and 1.0% net selling price increases.
  • 2Diluted Earnings Per Share (EPS) for the nine months increased to $2.43, up from $1.73 in the prior year period, reflecting strong profitability.
  • 3The company's "2004 Restructuring Program" is progressing on schedule, with an estimated cumulative pretax charge of $925-$1,075 million, aimed at enhancing global leadership and expected to yield annual savings of $400-$475 million by 2008.
  • 4Gross profit margin improved to 56.2% for the nine months ended September 30, 2007, up from 54.5% in the prior year, benefiting from cost-savings, product mix, and pricing.
  • 5Operating profit increased 29% to $1.98 billion for the nine months ended September 30, 2007, compared to $1.53 billion in the prior year, with significant growth across all operating segments.
  • 6Net cash provided by operations increased by 20% to $1.64 billion for the nine months ended September 30, 2007, indicating strong operational cash generation.
  • 7The company repurchased approximately 3.9 million shares of common stock during the third quarter of 2007 as part of its ongoing share repurchase program.

Frequently Asked Questions

Colgate-Palmolive's revenue growth was driven by a combination of factors including increased sales volume (7.0% for the nine months), strategic net selling price increases (1.0%), positive foreign exchange impacts (4.5%), and the successful divestment of less strategic businesses like the Latin American and Canadian bleach brands. The company also benefited from strong performance in its key segments, Oral, Personal, and Home Care, and Pet Nutrition, across various global markets.

The 2004 Restructuring Program is progressing as planned and is expected to contribute to long-term operational efficiencies and cost savings. While it has incurred substantial pretax charges (estimated $925-$1,075 million in total), these charges are expected to yield annual savings of $400-$475 million by 2008. The program has led to lower restructuring charges in the current period compared to the prior year, positively impacting operating profit and gross profit margins.

Colgate-Palmolive is involved in several legal and tax matters, particularly in Mexico and Brazil, concerning VAT credits, transfer pricing, and interest deductions. While these matters are being vigorously disputed and negotiated, management, based on legal counsel, believes they are without merit and not expected to have a material adverse impact on the company's financial position or ongoing results of operations. The company also noted ongoing investigations related to competition law in Europe.

The company generated strong operating cash flow of $1.64 billion for the nine months ended September 30, 2007. Financing activities included significant repurchases of treasury shares ($866.6 million) and dividend payments ($550.4 million). The company also issued Euro-denominated notes to pay down commercial paper. The Board approved a 13% increase in the annualized common stock dividend in the first quarter of 2007.